Press Releases

AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases

Advancing next-generation RESTORE+™ RNA editing platform based on pioneering research of founders Thorsten Stafforst and Jin Billy Li



Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides

Merkle T, Merz S, Reautschnig P, Blaha A, Li Q, Vogel P, Wettengel J, Li JB, Stafforst T. Nat Biotechnol 2019, 37:133-138, doi: 10.1038/s41587-019-0013-6, PMID: 30692694.


An RNA-deaminase conjugate selectively repairs point mutations

Stafforst T, Schneider MF. Angew Chem Int Ed Engl 2012, 51:11166-11169, doi: 10.1002/anie.201206489, PMID: 23038402.